Analyst consensus rating
Alto Neuroscience Analyst Rating: Strong Buy
ANRO is rated Strong Buy by 10 analysts with a $38.38 target. As of 2026-08-27.
Direct answer
Alto Neuroscience's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $38.38.
Forecast evidence checked August 27, 2026.
Get free Alto Neuroscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $36.30
- Average price target
- $38.38
- High price target
- $55.00
- Low price target
- $26.00
- Low target gap
- -28.4%
- Target upside
- +5.7%
- High target gap
- +51.5%
- Target range width
- 79.9%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Alto Neuroscience?
Alto Neuroscience has a verified Strong Buy consensus. The same dataset has an average price target of $38.38.
How far are Alto Neuroscience's low and high targets from the recorded price?
The low target implies -28.4%, while the high target implies +51.5%.
How many analysts are included in Alto Neuroscience's consensus?
The verified consensus includes 10 analysts.
How is Alto Neuroscience's target upside or downside calculated?
The average target of $38.38 is divided by the recorded price of $36.30, then one is subtracted to produce +5.7%. This does not guarantee a future return.
When was Alto Neuroscience's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.